Back to Journals » Vascular Health and Risk Management » Volume 4 » Issue 4

Determination of RBC membrane and serum lipid composition in trinidadian type II diabetics with and without nephropathy

Authors Nayak BS, Beharry VY, Armoogam S, Nancoo M, Ramadhin K, Ramesar K, Ramnarine C, Singh A, Singh A, Nwachi KU, Teelucksing S, Mathura R, Roberts L

Published 8 August 2008 Volume 2008:4(4) Pages 893—899

DOI https://doi.org/10.2147/VHRM.S2656


B Shivananda Nayak1, Vishi Y Beharry1, Shivani Armoogam1, Melinda Nancoo1, Kevin Ramadhin1, Kiron Ramesar1, Ciara Ramnarine1, Anandi Singh1, Anisha Singh1, Kingsley Uche Nwachi1, Surujpaul Teelucksing2, Ramesh Mathura3, Lesley Roberts4

1Department of Preclinical Sciences, Biochemistry Unit, 2Department of Clinical Science, The University of the West Indies, EWMSC, Trinidad and Tobago; 3Department of Diagnostic Laboratory Services, NCRHA, EWMSC, Trinidad and Tobago; 4Department of Medicine, Nephrology Unit, NCRHA, EWMSC, Trinidad and Tobago

Aim: The rheological properties of erythrocytes are impaired in diabetes mellitus, especially because of changes in their membrane lipid composition.The aim of this study was to determine and examine the relationship between red blood cell (RBC) membrane and serum lipid composition in type II diabetes subjects with and without nephropathy.

Methods: Trinidadian subjects aged 18–65 years were recruited for the study regardless of gender and ethnicity. Fasting blood samples were collected from 60 subjects of whom 20 were healthy individuals, 20 had type II diabetes without complications, and 20 were type II diabetics with nephropathy. Weight, height, waist/hip ratio, and blood pressure were recorded. All the blood samples were analysed to determine the serum lipid concentration, membrane lipid composition and plasma glucose concentration.

Results: The body mass index and the systolic blood pressure of the diabetics (28.17 ± 4.98 kg/m2, 153.21 ± 22.10 mmHg) and those with nephropathy (25.87 ± 4.68, 158.60 ± 22.49 mmHg) were higher when compared with controls (24.67 ± 5.18, 119.15 ± 13.03 mmHg). The diabetic (175.89 ± 102.73 μg/mgprotein) and diabetic nephropathy (358.80 ± 262.66) subjects showed significantly higher levels of RBC membrane cholesterol compared with controls (132.27 ± 66.47). The membrane phospholipids, protein and Na+/K+ATPase concentrations were altered in diabetics and diabetic nephropathy patients when compared with controls. The trends of increased serum cholesterol and decreased high-density lipoprotein in diabetics and diabetic nephropathy patients were noted as compared with controls but they are not significant as expected. The low-density lipoprotein cholesterol was significantly higher in diabetics when compared with diabetic nephropathy and control subjects.

Conclusions: Our data suggest that there is a relationship between RBC membrane and serum lipid composition in subjects with type II diabetes with and without nephropathy. This relationship shows that diet and lifestyle plays a significant role in the alterations of the lipids both in serum and RBC membrane. The membrane and serum lipid composition may be used as possible indicators for type II diabetic patients with and without nephropathy to control their diet in the beginning stages to prevent them from further complications.

Keywords: RBC membrane, phospholipids, protein, diabetes, diabetic nephropathy

Creative Commons License This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.

Download Article [PDF]